Determining site feasibility is something that most investigators and site coordinators are familiar with. However, once the questionnaire is filled out and provided back to the sponsor and/or CRO, sites may not be aware of the internal process a reviewing entity may have in evaluating the site’s feasibility for the study. As a former clinical research coordinator, I was curious about this. So, I decided to work with BBK's President Matt Kibby, who has been revolutionizing the site feasibility process for the past 20 years. Together, we worked to understand and provide greater context to current site staff regarding the way BBK views and evaluates sites for study feasibility.